ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0499

Drivers of Heterogeneity in Synovial Fibroblasts in Rheumatoid Arthritis

Melanie Smith1, Vianne Gao2, Edward DiCarlo1, Susan Goodman1, Thomas Norman2, Laura Donlin1, Christina Leslie2 and Alexander Rudensky2, 1Hospital for Special Surgery, New York, NY, 2Memorial Sloan Kettering Cancer Center, New York, NY

Meeting: ACR Convergence 2022

Keywords: cytokines, Fibroblasts, Synovial, immunology, rheumatoid arthritis, transcription factor

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 12, 2022

Title: Abstracts: RA – Etiology and Pathogenesis

Session Type: Abstract Session

Session Time: 3:00PM-4:00PM

Background/Purpose: Rheumatoid arthritis (RA) is characterized by hyperplasia of both the synovial lining, which forms the synovial fluid interface, as well as the synovial sublining, which exhibits increased vascularization and an influx of bone marrow-derived innate and adaptive immune cells. Both the lining and sublining fibroblast-like synoviocytes (FLS) exhibit altered phenotypes in RA, with recent studies demonstrating considerable heterogeneity (Alivernini, S et al. 2020, Nat Med; Mizoguchi, F et al. 2018, Nat Commun; Zhang, F et al. 2019, Nat Immunol). We hypothesized that states of FLS activation and differentiation throughout the synovium are likely modulated by diverse innate and adaptive immune cell types found in the inflamed synovium. We combined in vitro modeling of cytokine signaling, paired single cell RNA and ATAC sequencing (scRNA/ATAC-seq), and spatial transcriptomics (ST) to elucidate drivers of FLS heterogeneity in the RA synovium and define their spatial distribution.

Methods: Synovial tissue was obtained from a prospective cohort of RA patients undergoing arthroplasty or synovectomy who are screened for active RA at the time of surgery (HSS IRB no. 2014-233). Paired scRNA/ATAC-seq was performed on RA FLS (CD45–, CD31–, PDPN+) isolated from 2 donors with a high degree of lymphocytic inflammation. Nuclei suspensions were sequenced via Chromium Single Cell Multiome ATAC + Gene Expression (10x Genomics). To define FLS-specific cytokine-response signatures, FLS were cultured from 4 donors and stimulated with cytokines indicated in Fig 1 for 24 hours in triplicate. For ST, we used the Visium Spatial Gene Expression platform (10x Genomics) (2 donors).

Results: We obtained 15,736 FLS that clustered into 14 subtypes based on the scRNA-seq datasets (Fig 1). Gene set enrichment analysis and a cluster-by-cluster correlation refined the categorization into six robust FLS states with distinct inferred functionality. Mapping of cytokine response gene signatures to TNFα, IFNγ and IL-1β either alone or in combination established in vitro onto our scRNA-seq datasets revealed the most pronounced expression of these signatures in the cytokine-activated lining state. The states also occupied divergent areas of the scATAC-seq UMAP and exhibited differentially accessible transcription factor motifs (Fig 2): the cytokine-activated lining was enriched for activity of AP-1 transcription factor family members (e.g. FOS, JUN), whereas the activated sublining demonstrated accessibility of STAT and IRF motifs. The dominant AP-1 signature seen in the lining state correlated to the in vitro response involving IL-1β. Mapping the six FLS and cytokine response signatures onto the ST datasets revealed that the IL-1β response signature spatially correlated with the cytokine-activated lining FLS (Fig 3).

Conclusion: Our analysis of paired datasets allowed us to detect six FLS states that were defined by both distinct transcriptional signatures as well as patterns of chromatin accessibility. These states are driven by differential exposure to myeloid and T cell derived cytokines, IL-1α, TNFα, IFNγ, or lack thereof. Our results highlight a role for concurrent, spatially-distributed cytokine signaling within the RA synovium.

Supporting image 1

Figure 1. FLS in the inflamed RA synovium exist in distinct states driven by cytokine signaling.
A, UMAP of 14 FLS clusters identified by scRNA-seq analysis with annotations of synovial localization. B, Cluster by cluster correlation of the mean expression of highly variable genes in clusters with defined FLS states colored on UMAP. C, Dot plot showing relative expression of in vitro defined FLS-specific cytokine response signatures in each of the FLS states. Cultured FLS were stimulated with TNFa (0.1 ng/mL), IFNg(0.05 ng/mL), or IL_1b (0.01 ng/mL) alone or in combination for 24 hours followed by RNA isolation and bulk RNA seq.

Supporting image 2

Figure 2. FLS states exhibit evidence of distinct transcriptional regulation through differential chromatin accessibility.
A, Projection of six FLS states onto scATAC-seq UMAP. B, Heat map with top 10 differentially accessible transcription factor motifs identified by ChromVAR for each FLS state. Motifs were filtered to include only those for which the corresponding transcription factor was expressed by >20% of cells in the corresponding state. C, ChromVAR z-score of motifs from B in cultured FLS that were unstimulated, simulated with TNFa + IFNg, or stimulated with TNFa, IFNg and IL_1b.

Supporting image 3

Figure 3. FLS states and cytokine signaling are spatially constrained within the synovium.
A, Relative expression of FLS states in each RNA capture area on the ST slide. B, Relative expression of FLS cytokine response signatures in each RNA capture area on the ST slide.


Disclosures: M. Smith, None; V. Gao, None; E. DiCarlo, None; S. Goodman, Novartis, UCB; T. Norman, None; L. Donlin, None; C. Leslie, None; A. Rudensky, Sonoma Biotherapeutics, RAPT Therapeutics, Surface Oncology, Vendanta Biosciences, BioInvent.

To cite this abstract in AMA style:

Smith M, Gao V, DiCarlo E, Goodman S, Norman T, Donlin L, Leslie C, Rudensky A. Drivers of Heterogeneity in Synovial Fibroblasts in Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/drivers-of-heterogeneity-in-synovial-fibroblasts-in-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/drivers-of-heterogeneity-in-synovial-fibroblasts-in-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology